Home / Sweden / Dicot Pharma AB
Dicot Pharma AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
53 disclosures on record
Evolution of the disclosed total
0%1%2%3%4%
Oct 2025Jan 2026Apr 2026Jul 2026
August 20, 2024 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 7, 2026 | Citadel Securities (Europe) Limited | 0.55% | still open |
| June 22, 2026 | Guevoura Fund | 0.66% | still open |
| June 17, 2026 | Guevoura Fund | 1.10% | still open |
| June 16, 2026 | Guevoura Fund | 1.02% | still open |
| June 12, 2026 | Guevoura Fund | 0.92% | still open |
| June 11, 2026 | Guevoura Fund | 0.87% | still open |
| June 9, 2026 | Guevoura Fund | 0.66% | still open |
| June 4, 2026 | Guevoura Fund | 0.51% | still open |
| June 3, 2026 | Citadel Securities (Europe) Limited | 0.51% | still open |
| June 1, 2026 | Quartys Limited | 0.79% | still open |
| June 1, 2026 | Citadel Securities (Europe) Limited | 0.59% | still open |
| May 11, 2026 | Brummer Multi-Strategy AB | 0.62% | still open |
| March 27, 2026 | Brummer Multi-Strategy AB | 1.07% | still open |
| March 26, 2026 | Brummer Multi-Strategy AB | 0.98% | still open |
| March 18, 2026 | GSA Capital Partners LLP | 0.58% | still open |
| March 13, 2026 | Brummer Multi-Strategy AB | 0.75% | still open |
| March 12, 2026 | GSA Capital Partners LLP | 0.69% | still open |
| March 9, 2026 | GSA Capital Partners LLP | 0.78% | still open |
| March 4, 2026 | GSA Capital Partners LLP | 0.80% | still open |
| February 24, 2026 | GSA Capital Partners LLP | 0.70% | still open |
| February 16, 2026 | GSA Capital Partners LLP | 0.61% | still open |
| February 6, 2026 | GSA Capital Partners LLP | 0.51% | still open |
| January 30, 2026 | Brummer Multi-Strategy AB | 0.54% | still open |
| January 29, 2026 | Brummer Multi-Strategy AB | 0.66% | still open |
| January 28, 2026 | Brummer Multi-Strategy AB | 0.97% | still open |
| December 30, 2025 | Brummer Multi-Strategy AB | 1.32% | still open |
| November 19, 2025 | Citadel Securities (Europe) Limited | 0.53% | still open |
| November 14, 2025 | Citadel Securities (Europe) Limited | 0.62% | still open |
| November 13, 2025 | Citadel Securities (Europe) Limited | 0.57% | still open |
| November 11, 2025 | Citadel Securities (Europe) Limited | 0.68% | still open |
| November 10, 2025 | Citadel Securities (Europe) Limited | 0.59% | still open |
| November 7, 2025 | Citadel Securities (Europe) Limited | 0.75% | still open |
| November 4, 2025 | Citadel Securities (Europe) Limited | 0.84% | still open |
| October 30, 2025 | Citadel Securities (Europe) Limited | 0.79% | still open |
| October 29, 2025 | Citadel Securities (Europe) Limited | 0.56% | still open |
| October 27, 2025 | Brummer Multi-Strategy AB | 1.14% | still open |
| October 24, 2025 | Citadel Securities (Europe) Limited | 0.79% | still open |
| October 23, 2025 | Brummer Multi-Strategy AB | 1.42% | still open |
| September 2, 2025 | Brummer Multi-Strategy AB | 1.14% | still open |
| August 27, 2025 | Brummer Multi-Strategy AB | 0.90% | still open |
| August 26, 2025 | Brummer Multi-Strategy AB | 0.80% | still open |
| September 10, 2024 | Guevoura Fund | 1.25% | still open |
| September 6, 2024 | Guevoura Fund | 2.61% | still open |
| September 5, 2024 | Guevoura Fund | 2.55% | still open |
| September 4, 2024 | Guevoura Fund | 2.40% | still open |
| September 3, 2024 | Guevoura Fund | 2.37% | still open |
| September 2, 2024 | Guevoura Fund | 2.25% | still open |
| August 30, 2024 | Guevoura Fund | 2.10% | still open |
| August 27, 2024 | Guevoura Fund | 1.81% | still open |
| August 26, 2024 | Guevoura Fund | 1.43% | still open |
| August 23, 2024 | Guevoura Fund | 1.04% | still open |
| August 22, 2024 | Guevoura Fund | 0.95% | still open |
| August 20, 2024 | Guevoura Fund | 0.70% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.32% of the capital sold short
- Elekta AB (publ) 10.26% of the capital sold short
- JM AB 7.01% of the capital sold short
- Embracer Group AB 5.94% of the capital sold short
- Xvivo Perfusion Aktiebolag 5.61% of the capital sold short
- Hemnet Group AB (publ) 5.59% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Bonesupport Holding AB 5.38% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- Aktiebolaget Electrolux 4.12% of the capital sold short
- Stillfront Group AB (publ) 3.96% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short